Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qutenza in Post-surgical Neuropathic Pain
NCT04967664Phase 3Completed
- Sponsor
- Averitas Pharma, Inc.
- Start
- Jul 2021
- Primary completion
- Aug 2025
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of capsaicin 8% patch in neuropathic pain, sponsored by Averitas Pharma, Inc.. Started Jul 2021; status: completed.
02
Drugs
capsaicin 8% patch
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT04967664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04967664.